Reduced IL-2 and IL-4 mRNA Expression in CD4+ T Cells from Bovine Leukemia Virus-Infected Cows with Persistent Lymphocytosis  by Amills, Marcel et al.
Virology 304, 1–9 (2002)Reduced IL-2 and IL-4 mRNA Expression in CD4 T Cells from Bovine Leukemia
Virus-Infected Cows with Persistent Lymphocytosis
Marcel Amills, Vijayakumar Ramiya, Junzo Norimine, Colleen A. Olmstead, and Harris A. Lewin1
Department of Animal Sciences, Laboratory of Immunogenetics, University of Illinois at Urbana-Champaign, 210 Edward R. Madigan Laboratory,
1201 West Gregory Drive, Urbana, Illinois 61801
Received October 10, 2001; returned to author for revision November 20, 2001; accepted June 17, 2002
The role of T-helper (Th) responses in the subclinical progression of bovine leukemia virus (BLV) infection was explored
by determining the contribution of CD4 T cells to the expression of mRNAs encoding interferon- (IFN-), interleukin-2 (IL-2),
interleukin-4 (IL-4), and interleukin-10 (IL-10) in BLV-infected cattle. Relative levels of mRNA encoding IFN-, IL-2, IL-4, and
IL-10 were measured in fresh and concanavalin A (Con A) activated peripheral blood mononuclear cells (PBMCs) and purified
CD4 T cells from cows seronegative to BLV (BLV), seropositive without persistent lymphocytosis (BLVPL), and
seropositive with PL (BLVPL) using a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) assay.
The expressions of IFN-, IL-2, and IL-4 mRNAs were significantly reduced in the PBMCs from BLVPL cows as compared
to BLV cows. Reduced levels of IL-2 and IL-4 mRNAs were detected in fresh CD4 T cells from BLVPL cows. In contrast,
Con A stimulated PBMCs and CD4 T cells did not differ significantly in expression of IFN-, IL-2, IL-10, or IL-4 mRNAs among
the BLV infection groups. Using flow-sorted CD4 T cells and semiquantitative RT-PCR the frequencies of CD4 T cells
transcribing IFN-, IL-2, IL-4, and IL-10 mRNAs in the peripheral blood of BLV, BLVPL, and BLVPL cows were
determined. There were no significant differences in the frequencies of CD4 T cells expressing these cytokine mRNAs
among animals in the different BLV infection categories. Thus, the observed differences in IL-2 and IL-4 mRNAs in CD4 T
cells were due to changes in steady-state mRNA levels expressed by individual cells and not to changes in the frequency
of cells transcribing IL-2 and IL-4 mRNAs. These results demonstrate that the progression of BLV infection to PL isTh2
Science (INTRODUCTION
The bovine leukemia virus (BLV) is a delta-retrovirus, a
taxonomic group that includes the human T cell lympho-
tropic viruses (HTLVs), the simian T cell lymphotropic
viruses, and the baboon T cell leukemia virus. These
viruses share many common features of molecular orga-
nization and pathogenesis, including multiple provirus
integration sites in host DNA, transcriptional repression
of the provirus in vivo, chronic transforming potential,
persistence of infection despite a strong humoral im-
mune response, and resistance to progression of dis-
ease that is under genetic control of the host (Sagata et
al., 1985; Jensen et al., 1991; Xu et al., 1993; Kettmann et
al., 1994). A major difference between BLV and other
known delta-retroviruses is that B lymphocytes are the
primary target of BLV infection. Approximately 30% of
infected cows develop an advanced subclinical stage of
infection termed persistent lymphocytosis (PL) that is
characterized by polyclonal expansion of the CD5 B cell
subset, the majority of which harbors BLV provirus
(Kenyon and Piper, 1977; Mirsky et al., 1996). A small
fraction of BLV-infected cows (1–10%) develop lympho-1sarcoma, a fatal neoplastic disease that may involve
lymph nodes, abomasum, uterus, and other tissues
(Ferrer et al., 1979). Recent evidence suggests that inhi-
bition of DNA repair enzymes by BLV-tax may be a
necessary first step in the transformation process (Phil-
pott and Buehring, 1999).
Both genetic and immunological factors contribute to
susceptibility to PL and lymphosarcoma (reviewed in
Lewin et al., 1999). For example, the presence of glutamic
acid and arginine at positions 70–71 (peptide-binding
residues) of the 1 domain of BoLA-DRB3 major histo-
compatibility complex (MHC) class II alleles is strongly
associated with resistance to PL (Xu et al., 1993) and the
spread of BLV in vivo (Mirsky et al., 1998). Similarly,
resistance to the development of lymphoma in sheep
was associated with residues 70–71 of the major ex-
pressed sheep DR molecule (Nagaoka et al., 1999).
Resistance in sheep was also correlated with T cell
proliferative responses to epitopes on the major BLV
envelope glycoprotein gp51 (Nagaoka et al., 1999). Mul-
tiple lines of evidence suggest that cell-mediated immu-
nity plays an important role in limiting the spread of BLV
in vivo, consistent with MHC class II involvement inassociated with reduced expression of classical Th1 and
regulation in subclinically infected animals. © 2002 Elsevier
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envelope glycoprotein (gp51) were demonstrated in cat-
tle with PL (Callebaut et al., 1993; Mager et al., 1994) and
in sheep (Gatei et al., 1993a). These responses appear to
be driven mainly by the CD4 T cell subset (Callebaut et
al., 1993; Gatei et al., 1993b; Mager et al., 1994).
The demonstrable cell-mediated immune responses
to BLV epitopes, the significant changes in frequency of
B cell subsets, and the immunological aberrations ob-
served in PL cattle have led several investigators to
examine the expression of cytokines or cytokine mRNAs
in animals with advanced subclinical and clinical stages
of BLV infection. Diminished expression of IFN-, IL-2,
and IL-12 p40 mRNAs and increased IL-10 mRNA were
found in freshly isolated PBMCs from BLVPL and tu-
mor-bearing animals, thus suggesting a T-helper-2 (Th2)
response shift associated with PL (Pyeon et al., 1996;
Pyeon and Splitter, 1998). In support of these findings,
Keefe et al. (1997b) found that interferon- (IFN-) and
interleukin-2 (IL-2) mRNAs were reduced in T cells iso-
lated from the lymph nodes of cattle with PL. Although
these results suggest that the potential for cytokine pro-
duction differs in PBMCs from cows with PL and tumors,
Pyeon and co-workers (1996, 1998) did not control for the
number of T and B cells used for mRNA extractions.
Thus, it is unclear whether the observed changes in
cytokine mRNA expression were due to differences in
the frequency of T cells or other lymphoid subsets that
are altered as a result of BLV infection. In the present
study, we directly assessed the contribution of the CD4
T cell subset to IFN-, IL-2, IL-4, and IL-10 mRNA expres-
sion in BLV-infected cattle. In addition, the frequencies of
fresh peripheral blood CD4 T cells transcribing IFN-,
IL-2, IL-4, and IL-10 mRNAs were determined to under-
stand whether differences in transcript levels are due to
the changes in the numbers of cells expressing each
cytokine mRNA or to changes in level of expression
within the total CD4 T cell pool.
RESULTS
Cytokine mRNA expression in PBMCs
A semiquantitative RT-PCR assay was used to com-
pare the levels of cytokine mRNAs expressed by fresh
and concanavalin A (Con A) activated peripheral blood
mononuclear cells (PBMCs) from BLV, BLVPL, and
BLVPL cows. Reduced levels of IFN-, IL-2, and IL-4
mRNAs were found in PBMC from BLVPL cows when
compared to BLV animals (P  0.05, Fig. 1). Fresh
PBMCs from BLVPL cows transcribed less IFN- (P 
0.06) and IL-4 (P  0.05) mRNA than did BLV cows (Fig.
1). The only significant comparison (P  0.05) between
BLVPL and BLVPL animals was for IL-2 mRNA,
which was significantly lower in PBMCs among cows
with PL, although expression of IL-10 mRNA also tended
to be reduced (P  0.1). When PBMCs were cultured for
24 h with Con A, there were no significant differences in
expression of cytokine mRNAs among the three groups
of cows (Fig. 2).
FIG. 1. Mean cytokine mRNA expression in fresh PBMCs from BLV (n  7), BLVPL (n  7), and BLVPL cows (n  7). Means are expressed
as the ratio of the cytokine/GAPDH IDV. Error bars denote standard errors. Means with different letters indicate significant differences (P  0.05).
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Cytokine mRNA expression in CD4 T cells
The expressions of cytokine mRNAs were compared
in immunomagnetic bead-purified CD4 T cells. Re-
duced expression of IL-2 and IL-4 mRNAs was observed
in fresh CD4 T cells from cows with PL as compared to
BLV animals (P 0.05), whereas the levels of IFN- and
IL-10 mRNAs were similar among the BLV infection
groups (Fig. 3). In addition, fresh, purified CD4 T cells
from animals with PL expressed less IL-2 mRNA than
BLVPL animals. Among the cows with PL, IL-2, and
IL-4 mRNA, levels were approximately four- and threefold
greater in purified fresh CD4 T cells than in fresh PB-
MCs, respectively (compare Figs. 1 and 3). Similar re-
sults were observed for both IL-2 and IL-4 in BLVPL
and BLV animals, demonstrating that CD4 T cells are
a major source of IL-2 and IL-4 in cattle. In contrast, the
levels of IL-10 mRNA were not different in fresh CD4 T
cells compared to fresh PBMCs from cows with PL,
although Con A stimulation of PBMC and CD4 T cells
from cows with PL produced approximately a twofold
increase in IL-10 mRNA relative to fresh PBMC and fresh
CD4 T cells from PL cows. Thus, although IL-10 is
known to be produced primarily by monocyte/macro-
phage in cattle (Pyeon et al., 1996), IL-10 may be also be
produced by CD4 T cells. The activation of CD4 T cells
from BLVPL cows with Con A resulted in a marked
increase in the levels of IL-2 and IL-4 mRNA, reaching
values comparable to BLV and BLVPL animals
(Fig. 4).
Frequencies of CD4 T cells transcribing cytokines in
peripheral blood
Preliminary cell-sorting and cell-frequency analysis
revealed that less than 1% of fresh CD4 T cells
expressed any given cytokine mRNA (data not shown).
Therefore, a multicell sorting approach was used to
determine the relative frequencies of CD4 T cells
transcribing IFN-, IL-2, IL-4, and IL-10 mRNAs. Among
the infection groups, there was no significant differ-
ence in the frequencies of CD4 T cells transcribing
any of the cytokine mRNAs tested (Table 1). The fre-
quency of fresh CD4 T cells transcribing IL-2 ranged
from 2.7- to 4.7-fold greater than the frequency of
CD4 T cells transcribing IFN-, depending on BLV
infection group. These results demonstrate that the
transcription of the Th1 cytokines IL-2 and IFN- is
regulated independently in cattle. Similarly, the fre-
quency of CD4 T cells transcribing IL-10 was up to
3.6-fold higher than the frequency of CD4 T cells
transcribing IL-4, demonstrating that the transcription
of these cytokines is decoupled in cattle. Thus, differ-
ences in the levels of cytokine mRNA expression
found in fresh cells among animals grouped by infec-
tion status are likely to be due to differences in steady-
FIG. 2. Mean cytokine mRNA expression in Con A activated PBMCs from BLV (n  7), BLVPL (n  7), and BLVPL cows (n  7). Means are
expressed as the ratio of the cytokine/GAPDH IDV. Error bars denote standard errors.
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FIG. 3. Mean cytokine mRNA expression in fresh CD4 T cells from BLV (n  8), BLVPL (n  8), and BLVPL cows (n  9). Means are
expressed as the ratio of the cytokine/GAPDH IDV. Error bars denote standard errors. Means with different letters are different (P  0.05).
FIG. 4. Mean cytokine mRNA expression in Con A activated CD4 T cells from BLV (n  8), BLVPL (n  8), and BLVPL cows (n  9). Means
are expressed as the ratio of the cytokine/GAPDH IDV. Error bars denote standard errors.
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state mRNA levels within individual CD4 T cells, not
the number of transcriptionally active cells.
DISCUSSION
Levels of IFN-, IL-2, IL-4, and IL-10 transcripts in fresh
PBMCs and purified CD4 T cells from BLV, BLVPL,
and BLVPL cows were studied to determine whether
BLV infection and disease progression are associated
with perturbations in Th cytokine mRNA expression pro-
files. Cytokines were chosen to represent classical Th1-
and Th2-like mediators. In addition, we estimated the
fractions of cells expressing these cytokine mRNAs to
determine whether differences in transcript levels
among the groups were due to changes in the steady-
state levels of mRNA on an individual cell basis or to
increases in the frequencies of cells expressing the
different cytokine mRNAs. Previously, Pyeon et al. (1996)
showed that PBMCs from BLVPL cows transcribe sig-
nificantly less IFN- and IL-2 mRNAs than BLVPL
cows and that PBMCs from BLVPL cows transcribe
much higher levels of IL-10 mRNA than the PBMCs from
BLVPL and BLV cows. These authors suggested that
IL-10 plays a key role in the progression of the disease
by inducing a Th2 polarization of the immune response.
The results of Pyeon and co-workers are at odds with
ours in that we found the levels of IL-10 mRNA in fresh
PBMC not to be different in BLVPL and BLV cows. In
addition, BLVPL cows’ PBMCs tended to have in-
creased IL-10 mRNA levels relative to both BLV and
BLVPL cows in our study. Although these discrepan-
cies may be attributed to differences in technical ap-
proach (see below), it is not likely that a Th2 shift causes
PL because there is no convincing evidence that IL-10
behaves as a Th2 cytokine in cattle (Brown et al., 1993,
1994a,b, 1998). In addition, we found IL-4 mRNA expres-
sion in the CD4 T cells of all tested animals, with
expression levels significantly greater in uninfected an-
imals than in infected animals. Thus, results obtained for
IL-10 and IL-4 (Romagnani, 1997) do not support the idea
that a positive Th2 shift is a key factor in the polyclonal
expansion of BLV-infected B cells observed in animals
with PL. We believe that other factors, such as MHC
class II mediated effects on Th1 responses (Mirsky et al.,
1998), enhanced clonal proliferation of BLV-infected B
cell precursors, or resistance to apoptosis (Cantor et al.,
2000), are more likely to be responsible for the develop-
ment and maintenance of the PL state. The reason for
the decreased IL-4 mRNA levels in cows with PL and its
immunological significance remains to be elucidated.
The numbers of T cells used in the assays were not
standardized in previous studies of cytokine mRNA ex-
pression and BLV infection (Keefe et al., 1997a; True-
blood et al., 1998; Pyeon and Splitter, 1999). Cattle with
PL will often have 25% the normal percentage of T cells
in peripheral blood (Mirsky et al., 1996). This change is
directly attributable to the polyclonal expansion of BLV-
infected CD5 B cells in BLV-infected animals (Mirsky et
al., 1998). Therefore, it is difficult to draw meaningful
conclusions from earlier studies in which a fixed number
of fresh or cultured PBMC were used for mRNA extrac-
tion because the absolute number of T cells in such
cultures can vary fourfold among infected and uninfected
animals. The present study examined both PBMC and
CD4 T cells for cytokine mRNA levels, thus allowing
comparison with results of previous studies and direct
comparisons of transcript levels in equal numbers of
CD4 T cells. We observed a significant reduction in IL-2
and IL-4 mRNA in both fresh PBMC and purified CD4 T
cells in cattle with PL. These results are consistent with
those of Keefe et al. (1997a,b), who found decreased
levels of IL-2 mRNA and no change in IL-10 mRNA in
lymph node T cells from cattle with PL (IL-4 was not
measured). In addition, these results support earlier find-
ings demonstrating that CD4 peripheral T cells are a
primary source of IL-2 and IL-4 transcripts. The high
percentage of B cells in the preparations would not affect
the IL-2 and IL-4 mRNA content of the fresh PBMC and
PBMC cultures because these cytokines are not pro-
duced by cattle B cells. Although T cell percentage and
absolute numbers could account for the differences ob-
served in IL-2 and IL-4 mRNA levels among infection
groups, this would not be a factor in the purified CD4 T
cells. In contrast, the lower expression of IFN- mRNA in
fresh PBMC as compared to fresh CD4 T cells in PL
cattle (Figs. 1 and 3) suggests either an effect of T cell
concentration or another source of IFN- mRNA in the
peripheral T cell pool exists which is deficient in its
ability to produce IFN- mRNA. The latter explanation is
plausible because CD8 T cells (Rhodes et al., 1999) and
/ T cells (Rhodes et al., 2001) have been shown to be
a major source of IFN- mRNA expression in cattle.
There was no correlation between the frequency of
IL-2 and IL-4 mRNA levels and the frequency of unstimu-
lated CD4 T cells transcribing these cytokine mRNAs
TABLE 1
The Frequencies of Fresh CD4 T Cells Transcribing IFN-, IL-2,








IFN- 0.089 0.016 0.137 0.021 0.132 0.031
IL-2 0.414 0.138 0.366 0.093 0.378 0.135
IL-4 0.028 0.008 0.039 0.006 0.053 0.010
IL-10 0.058 0.023 0.142 0.064 0.142 0.040
a PMBCs were labeled with anti-CD4 and sorted into microtiter
plates (100 or 500 cells/well). RT-PCR was performed as described
under Materials and Methods. An algorithm was used to convert the
percentages of positive and negative wells into cell frequencies ex-
pressing each cytokine, as described by Mirsky et al. (1993). Results
are expressed as mean frequencies (%)  standard errors.
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(Table 1). These findings suggest that the decrease in
IL-2 and IL-4 mRNA expression in CD4 T results from a
reduced steady-state mRNA level on a single-cell basis
and not from a reduced frequency of CD4 T cells pro-
ducing these cytokine mRNAs. It is clear from the fre-
quency analysis that cellular expression of the cytokine
mRNAs only partially overlaps, thus demonstrating that
there is no clear-cut Th1 or Th2 phenotype in cattle. It is
relevant that CD4 T cell clones derived from cattle
infected with Babesia bovis, B. Bigemina, or Fasciola
hepatica can simultaneously transcribe the IFNG and IL4
genes (Brown et al., 1998), clearly supporting our results
obtained with purified CD4 T cells. Thus, we did not find
any evidence at the level of cell-frequency analysis for
the clonal expansion of Th2 effectors in cows with PL, a
result that agrees well with our semiquantitative reverse
transcription-polymerase chain reaction (RT-PCR) analy-
sis.
Mitogen-stimulated PBMCs from cows with PL have
been reported to overexpress IL-2 and IL-10 and to
down-regulate expression of IL-12 p40 (Keefe et al.,
1997a,b; Trueblood et al., 1998; Pyeon and Splitter, 1999).
Our analysis of IL-2, IL-4, IL-10, or IFN- transcript levels
in Con A activated PBMCs did not reveal any significant
differences among BLV, BLVPL, and BLVPL cows,
although activated PMBCs from BLVPL cows tended
to express less IL-2 than BLV and BLVPL cows. This
was in marked contrast to the results obtained with fresh
PBMC and CD4 T cells from PL cows that expressed
reduced levels of IL-2 and IL-4 mRNA. These results
indicate that CD4 T cells from PL cows are able to
mount vigorous IL-2 and IL-4 responses when poly-
clonally activated. Moreover, the very large increase in
IL-2 expression by Con A stimulated CD4 T cells from
PL cows as compared with unstimulated cells is consis-
tent with the results of others (Stone et al., 2000). Al-
though the mechanism of IL-2 hyperresponsiveness of T
cells from PL cattle in vitro is unclear, it has recently
been shown to be associated with the expression of BLV
by infected B cells (Stone et al., 2000; J. Norimine and
H. A. Lewin, unpublished observations). It was proposed
that up-regulation of IL-2 may be caused by the transac-
tivation of the IL2 gene in T cells by a soluble BLV protein
(Trueblood et al., 1998). Alternatively, we favor the hy-
pothesis that the expression of BLV antigens by infected
B cells in vitro may lead to a polyclonal T cell activation.
Recombinant IL-2 increases the expression of the IL-2
receptor -chain and the BLV p24 protein in B cells
isolated from BLVPL cows, supporting the existence of
a positive feedback loop between IL-2 and viral expres-
sion (Stone et al., 1995; Trueblood et al., 1998).
Although BLV-infected cows do not show clear signs
of immunosuppression, there is evidence indicating that
their life span is shorter and that their productive perfor-
mance is impaired (Wu et al., 1989; Brenner et al., 1989;
Da et al., 1993). Moreover, immune dysfunctions have
been reported in cows with PL, such as a decrease in the
cytotoxic activity of CD8 T cells (Yamamoto et al., 1984),
the polyclonal expansion of CD5 B cells (Mirsky et al.,
1996), and a reduction in the phagocytic ability of mono-
cytes or macrophages (Werling et al., 1998). We have
demonstrated that both Th1 (IL-2) and Th2 (IL-4) cytokine
mRNA expression is reduced in the CD4 T cell subset
of BLVPL cows and that IFN-mRNA expression might
also be down-regulated in the CD8 T cell compartment.
These findings, in conjunction with the observation that
CD4 T cells from cows with PL show a diminished
proliferative response to BLV gag and env antigens (Orlik
and Splitter, 1996), indicate that the functionality of the
CD4 T cell subset becomes gradually compromised as
the disease progresses. The mechanism that results in
the apparent down-regulation of IL-2 and IL-4 mRNA
expression is at present unclear. A possible mechanism
might involve anergy induced by chronic exposure to BLV
antigens as has been observed for mice infected with
murine leukemia viruses (Fitzpatrick et al., 1992, Mu-
ralidhar et al., 1996). Further experiments will be required
to understand if aberrant cytokine responses are a direct
cause or the consequence of the immunological abnor-
malities observed in BLV-infected cattle. Moreover, it will
be important to determine how these changes relate to
the genetic differences of cattle in susceptibility to PL (Xu
et al., 1993).
MATERIALS AND METHODS
Animals and BLV infection status
All cattle were reared and maintained at the University
of Illinois dairy research facility. BLV infection status was
determined by using agar gel immunodiffusion to test for
antibodies to the major BLV envelope glycoprotein, gp51
(Leukassay B, SynBiotics, Kansas City, MO). Persistent
lymphocytosis among infected cows was defined on the
basis of a standard hematological key (Mammerickx et
al., 1978). The definition of PL is based upon significantly
elevated lymphocyte counts in consecutive blood sam-
ples collected at least 3 months apart (Mammerickx et
al., 1978). Between seven and nine cows in each of three
BLV infection categories were selected for study. These
categories were BLV (seronegative), BLVPL (sero-
positive, not PL), and BLVPL (seropositive with PL).
Cell separation, CD4 T cell isolation, and Con A
stimulation
Peripheral blood was collected by jugular venipunc-
ture into acid-citrate dextrose (Vacutainer, Beckton–Dick-
inson Co., Rutherford, NJ). Buffy coat was harvested
following centrifugation at 1000 g for 10 min and diluted
1:1 in phosphate-buffered saline (PBS, pH 7.4) containing
0.6% sodium citrate (Sigma, St. Louis, MO). Diluted cells
were layered over Histopaque-1077 (Sigma) and centri-
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fuged at 1000 g for 20 min. Peripheral blood mononuclear
cells were removed from the gradient interface and
washed three times in ice-cold PBS at 400 g for 10 min.
Viability was assessed on a hemocytometer using 0.2%
trypan blue. CD4 T cells were isolated using an im-
munomagnetic separation technique. Briefly, PBMCs
were resuspended in ice-cold citrate–PBS to a con-
centration of 5  107 cells/ml and incubated for 30 min
with 10 g/ml of monoclonal mouse anti-bovine CD4
(CACT138A, VMRD Inc., Pullman, WA). After three wash-
ings with chilled PBS, cells were resuspended in ice-cold
PBS and incubated with 1 108 magnetic beads (45 m)
conjugated to goat anti-mouse IgG (Dynal, Oslo, Nor-
way). The bead-bound cells were harvested using a
Dynal Magnetic Particle Concentrator (Dynal) and
washed extensively before release of bound cells by
repeated aspiration with a 1-ml tuberculin syringe. The
purified population contained 90% CD4 T cells as
determined using flow cytometry.
The cytokine mRNA expression profiles of PBMCs and
CD4 T cells were studied before and after activation
with Con A (Boehringer Mannheim, Indianapolis, IN).
Aliquots of freshly isolated PBMCs and purified CD4 T
cells were resuspended in Trizol reagent (Gibco-BRL,
Grand Island, NY) immediately after isolation. Additional
aliquots were cultured in RPMI 1640 medium supple-
mented with 10% fetal bovine serum (Harlan, Indianapo-
lis, IN) and Con A (10 g/ml) (Boehringer Mannheim).
Cells were cultured in flat-bottom 96-well plates (Fisher
Scientific, Pittsburgh, PA) at a concentration of 5  105
cells/well (37°C, 5% CO2). To mimic the physiological
process of T cell activation, CD4 T cells were stimu-
lated in the presence of autologous antigen-presenting
cells. Briefly, 1  106 autologous PBMCs were incubated
for 1 h at 37°C (5% CO2); the nonadherent fraction was
removed by extensive washings with cold PBS, and the
purified CD4 T cells were seeded into 96-well plates.
After 24 h, PBMCs and purified CD4 T cells were har-
vested and resuspended in Trizol reagent (Gibco-BRL).
Semiquantitative reverse transcription-polymerase
chain reaction
Cells were suspended in 1 ml Trizol (Gibco-BRL) and
total RNA was isolated according to the manufacturer’s
instructions. Reverse transcription reactions were per-
formed in a 50 l containing RT buffer (25 mM Tris–HCl
pH 8.3, 37.5 mM KCl, 1.5 mM MgCl2), 1 mM dithiothreitol
(DTT), 2 M oligo(dT16), 250 M of each dNTP and 200 U
Moloney murine leukemia virus reverse transcriptase
(Gibco-BRL). The amount of RNA used as a template for
cDNA synthesis was 1 g for fresh PBMCs and CD4 T
cells and 0.5 g for cultured cells. RNA was incubated at
65°C for 10 min and subsequently placed on ice for 5
min. Reactions were performed at 42°C for 1 h followed
by an inactivation step at 94°C for 10 min. The efficiency
of the RT reaction was assessed by using the gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as a control. The oligonucleotides used for RT and PCR
amplification of IFN-, IL-2, IL-4, IL-10, and GAPDH
cDNAs are listed in Table 2. In preliminary experiments,
the detection of each one of the target cytokine cDNAs
was optimized by visually examining the intensity of the
amplified products after 29 to 35 cycles of PCR. These
experiments ensured that the PCR was terminated in the
exponential phase and, consequently, the band intensity
reflected differences in the amount of starting template
cDNA. The PCR reactions were performed in 50 l con-
taining PCR buffer (10 mM Tris, 50 mM KCl pH 8.3), 2.5
mMMgCl2, 0.2 M of each primer, 200 M of each dNTP,
5 l of the RT reaction as template, and 1 U of thermo-
stable DNA polymerase (AmpliTaq, Perkin–Elmer,
Branchburg, NJ). The PCR profile was 94°C for 4 min
followed by 31 cycles (cultured cells) or 35 cycles (fresh
cells) or 29 cycles (IL-10 in fresh PBMCs) of 94°C for 1
min, 57°C for 1 min, 72°C for 1 min and a final extension
step of 72°C for 5 min.
A digital imaging system (IS1000 Alpha Innotech Corp.,
San Leandro, CA) was used to measure the intensity of
the bands generated by PCR. Preliminary experiments
revealed intragel and intergel variation in the determina-
tion of the integrated density value (IDV). Intergel varia-
tion depended on the electrophoretic and staining con-
ditions, so these procedures were standardized to obtain
repeatable estimates of the IDV. In preliminary experi-
ments we found that the best results were obtained by
running 5 l of the PCR product in 6% non-denaturing
polyacrylamide minigels at 100 V for 1.5 h. The gels were
stained in 1 TBE with ethidium bromide (0.5 g/ml) for
TABLE 2
List of Primers Used for the Amplification of IFN-, IL-2, IL-4, IL-10,
CD3, and GAPDH mRNAs
Primers Primer sequence (5-3) PCR product size
(1) IFN-5 ATCATAACACAGGAGCTACC 338 bp (1  2)
(2) IFN-3 ATCCATGCTCCTTTGAATGACC 192 bp (1  3)
(3) IFN-3in CTACATCTGGGCTACTTGCATT
(4) IL2-5 CAACTCTTGTCTTGCATTGCAC 356 bp (4  5)
(5) IL2-3 GTTTCAGATCCCTGTAGTTCCA 172 bp (4  6)
(6) IL2-3in ATGTATGCATCCTGGAGAGCTT
(7) IL-4-5 CTCACCTACCAGCTGATCCCA 313 bp (7  8)
(8) IL4-3 CAGAACAGGTCTTGCTTGCCA 210 bp (8  9)
(9) IL4-5in CGCTGAACATCCTCACAACGA
(10) IL10-5 CTGTCTGACAGCAGCTGTATCC 265 bp (10  11)
(11) IL10-3 CCAGTGAGTTCACGTGCTCCTT 169 bp (10  12)
(12) IL10-3in GGCAACCCAGGTAACCCTTAAA
(13) CD3-5 GGACTCTGCCTCTTATTAGTTG 304 bp (13  14)
(14) CD3-3 GATTCACCTCCATGCAGTTCTTA 223 bp (14  15)
(15) CD3-5in ACTGTTGAGCTGACATGCCCTA
(16) GAPDH-5 TCTCGCTCCTGGAAGATGGT 231 bp (16  17)
(17) GAPDH-3 GAAGGTCGGAGTCAACGGAT
Note. in denotes an internal primer.
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10 min. If equal amounts of a given PCR product were
loaded in the outer lanes of the gel, the IDV measure-
ment was lower than if they were loaded in the central
lanes. To correct for this source of intragel variation, we
coloaded a 223-bp standard control (SC) in each lane.
Thus, we first corrected the IDV values for gel-positional
effect by using the SC as a reference [corrected cytokine
IDV (A)  IDV/SC IDV; GAPDH IDV (B)  IDV/SC IDV].
Next, we normalized the corrected cytokine IDVs to the
corrected GAPDH IDV (A/B  corrected cytokine IDV).
This method ensures that variations in the intensity of the
PCR products were due exclusively to differences in the
initial amount of cDNA templates. Semiquantitative data
were analyzed with a general linear models procedure
(SAS version 6.11, Cary, NC) in which treatment effect
was the disease category and the dependent variables
were the corrected and normalized IDVs for the four
cytokines (TRT  IFN-  IL-2  IL-4  IL-10). Differ-
ences in cytokine mRNA expression among disease cat-
egories were tested by analysis of variance (SAS). Each
data set (fresh PBMCs, cultured PBMCs, fresh CD4 T
cells, and cultured CD4 T cells) was analyzed indepen-
dently.
Frequency analysis of cytokine-expressing CD4 T
cells
The frequencies of CD4 T cells transcribing cytokine
mRNAs were determined by flow cytometry combined
with RT-PCR for detecting gene expression in single or
multiple cells distributed in microtiter plates according to
previously published methods (Mirsky et al., 1996; Gay-
nor et al., 1996). Briefly, PBMCs were labeled with the
CACT138A anti-CD4 primary antibody (VMRD) and the
phycoerythrin-conjugated anti-mouse IgG1 secondary
antibody (Southern Biotechnology Inc., Birmingham, AL).
An EPICS 751 flow cytometer (Coulter Electronics, Hi-
aleah, FL) equipped with a deposition unit for single-cell
sorting was used to sort 100 or 500 CD4 T cells into
wells of 96-well Concord-25 microtiter plates (MJ Re-
search, Watertown, MA). Each well contained 10 l lysis
buffer (153 mM KCl, 6.38 mM MgCl2, 102 mM Tris, 0.051%
Nonidet P-40) and 8 U RNAsin (Promega, Madison, WI).
After the sorting step, 10 l of the RT mixture and five
primers complementary to the 3 end of the targeted
mRNAs were added. The final concentrations of re-
agents were 250 M dNTPs, 2.5 M DTT, 10 U/l of
Mu-MLV reverse transcriptase, and 0.4 M of each
primer. The thermal profile of the RT reactions was 65°C
for 10 min, 42°C for 1 h, and 94°C for 10 min. Subse-
quently we amplified the IFN-, IL-2, IL-4, and IL-10
cDNAs by using a PCR protocol that employed primer
heminesting. We also amplified the CD3 subunit cDNA
as a positive control for ascertaining which wells con-
tained T cells. The RT reaction was split into two different
multiplex amplification reactions (PCR1 and PCR2). PCR1
contained primers for IFN-, IL-2, and CD3; PCR2 con-
tained primers for IL-4 and IL-10 (Table 2). The volume of
both PCRs was 25 l, with final concentration of 1.8 mM
MgCl2, 400 M dNTPs, 0.4 M of each primer, 10 l of
RT reaction, and 0.1 U of Taq polymerase. The thermal
profile consisted of 94°C for 4 min followed by 40 cycles
of 94°C for 1 min and 57°C for 1 min with a final
extension step of 72°C for 5 min. Independent, second-
round PCRs with heminested primers were performed
with the PCR1 and PCR2 first-round amplification prod-
ucts. Five microliters of PCR1 was used for separately
amplifying IFN-, IL-2, and CD3 cDNAs, whereas 5 l of
PCR2 was used for amplifying IL-4 and IL-10 cDNAs.
Each one of the five different second-round PCRs con-
tained 5 l buffer (500 mM KCl, 100 mM Tris, 25 mM
MgCl2), 100 M dNTPs, 0.4 M of each primer, and 1 U
Taq polymerase in 50 l. The second-round PCRs con-
sisted of an initial denaturation step of 94°C for 4 min
followed by 30 cycles of 94°C for 1 min, 60°C for 1 min,
and 72°C for 30 s and a final extension step of 72°C for
5 min. The PCR products were electrophoresed in 6%
non-denaturing polyacrylamide minigels and stained
with ethidium bromide. The percentages of cells tran-
scribing cytokine mRNAs were determined using an al-
gorithm that takes into account amplification efficiency
(Mirsky et al., 1993). The method is accurate for wells
containing one cell or many cells (Mirsky et al., 1993).
Frequencies of cells transcribing cytokine mRNAs were
compared among animals classified according to BLV
infection status using analysis of variance (SAS).
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